Prospective, controlled, single-blind, bicentric, randomized study on the safety of HES 130/0.42 comb. with a balanced electrolyte solution vs. 5% albumin comb. with an unbalanced electrolyte solution (NaCl 0.9%) in patients with compensated renal failure

Infusion of Venofundin® 6% or Tetraspan® 6% in Paediatric Patients aged up to 12 Years

Evaluation on the safety profile of Venofundin® 6% and Tetraspan® 6% in the Asian-Pacific Region

Perioperative Blood Volume Changes Caused by Hemorrhage and Fluid Therapy During Urologic Surgery